Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

NCT03409315 · clinicaltrials.gov ↗

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Multidrug-Resistant

Interventions

PROCEDURE: Centralized Therapeutic Drug Monitoring

Sponsor

University Medical Center Groningen